Niagen Bioscience, Inc. (NAGE)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 30, 2017	Dec 31, 2016
Ingredients	28.68M	19.81M	11.14M	8.74M	7.41M
Ingredients Growth	44.72%	77.91%	27.48%	17.94%	-19.47%
Analytical Reference Standards and Services	3.08M	3.01M	2.91M	3.20M	3.34M
Analytical Reference Standards and Services Growth	2.16%	3.65%	-9.33%	-3.99%	12.39%
Consumer Products	97.67M	76.77M	69.53M	60.11M	56.71M
Consumer Products Growth	27.22%	10.42%	15.67%	6.00%	20.42%
Total	129.42M	99.60M	83.57M	72.05M	67.45M
Total Growth	29.95%	19.18%	15.99%	6.82%	13.82%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 30, 2017	Dec 31, 2016
International	27.80M	24.30M	25.00M	21.80M	19.80M
International Growth	14.40%	-2.80%	14.68%	10.10%	-1.00%
United States	101.62M	75.30M	58.57M	50.25M	47.65M
United States Growth	34.96%	28.56%	16.56%	5.46%	21.38%
Total	129.42M	99.60M	83.57M	72.05M	67.45M
Total Growth	29.95%	19.18%	15.99%	6.82%	13.82%

Data Source: S&P Global Market Intelligence Last updated: May 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error